Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
2.94
-0.08 (-2.65%)
At close: Jun 23, 2025, 3:59 PM
2.99
1.70%
Pre-market: Jun 24, 2025, 05:17 AM EDT
Spero Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Collaboration Revenue Related Party Revenue | 27.02M |
| Collaboration Revenue Related Party Revenue Growth | n/a |
| Collaboration Revenue Revenue | 371K |
| Collaboration Revenue Revenue Growth | n/a |
| Grant Revenue Revenue | 20.58M |
| Grant Revenue Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.82M | 7.06M | 5.2M | 5.53M | 5.92M | 6.43M | 5.71M | 6.1M | 7.32M | 6.5M | 6.63M | 8.05M | 15.3M | 13.02M | 11.15M | 9.23M | 8.3M | 7.5M | 5.31M | 4.55M | 4.09M | 3.79M | 4.13M | 3.78M | 3.89M | 3.65M | 3.13M | 3.06M | 3.04M | 2.49M | 3.65M | 2.96M | 1.74M | 2.22M | 1.91M |
| Selling, General, and Administrative Revenue Growth | -3.29% | +35.74% | -6.05% | -6.49% | -8.02% | +12.70% | -6.36% | -16.69% | +12.66% | -2.07% | -17.63% | -47.40% | +17.54% | +16.76% | +20.84% | +11.21% | +10.68% | +41.23% | +16.76% | +11.28% | +7.95% | -8.42% | +9.28% | -2.73% | +6.55% | +16.43% | +2.42% | +0.53% | +22.25% | -31.84% | +23.54% | +69.94% | -21.55% | +16.19% | n/a |
| Research and Development Revenue | 13.61M | 28.84M | 26.86M | 23.73M | 17.33M | 16.52M | 16.39M | 9.51M | 8.98M | 15.09M | 7.36M | 8.17M | 16.97M | 17.23M | 14.44M | 14.46M | 18.4M | 13.21M | 17.71M | 15.66M | 20.44M | 25.73M | 18.5M | 12.03M | 9.53M | 9.13M | 8.46M | 7.37M | 8.93M | 12.5M | 6.91M | 7.46M | 6M | 6.93M | 6M |
| Research and Development Revenue Growth | -52.82% | +7.34% | +13.23% | +36.89% | +4.92% | +0.77% | +72.38% | +5.91% | -40.49% | +105.01% | -9.95% | -51.84% | -1.47% | +19.32% | -0.17% | -21.42% | +39.37% | -25.42% | +13.09% | -23.39% | -20.57% | +39.11% | +53.79% | +26.24% | +4.37% | +7.90% | +14.71% | -17.38% | -28.62% | +80.94% | -7.34% | +24.30% | -13.40% | +15.35% | n/a |